Literature DB >> 30376191

Regional subcortical shape analysis in premanifest Huntington's disease.

Xiaoying Tang1, Christopher A Ross2, Hans Johnson3, Jane S Paulsen3, Laurent Younes4,5,6, Roger L Albin7,8, J Tilak Ratnanather5,6,9, Michael I Miller5,6,9.   

Abstract

Huntington's disease (HD) involves preferential and progressive degeneration of striatum and other subcortical regions as well as regional cortical atrophy. It is caused by a CAG repeat expansion in the Huntingtin gene, and the longer the expansion the earlier the age of onset. Atrophy begins prior to manifest clinical signs and symptoms, and brain atrophy in premanifest expansion carriers can be studied. We employed a diffeomorphometric pipeline to contrast subcortical structures' morphological properties in a control group with three disease groups representing different phases of premanifest HD (far, intermediate, and near to onset) as defined by the length of the CAG expansion and the participant's age (CAG-Age-Product). A total of 1,428 magnetic resonance image scans from 694 participants from the PREDICT-HD cohort were used. We found significant region-specific atrophies in all subcortical structures studied, with the estimated abnormality onset time varying from structure to structure. Heterogeneous shape abnormalities of caudate nuclei were present in premanifest HD participants estimated furthest from onset and putaminal shape abnormalities were present in participants intermediate to onset. Thalamic, hippocampal, and amygdalar shape abnormalities were present in participants nearest to onset. We assessed whether the estimated progression of subcortical pathology in premanifest HD tracked specific pathways. This is plausible for changes in basal ganglia circuits but probably not for changes in hippocampus and amygdala. The regional shape analyses conducted in this study provide useful insights into the effects of HD pathology in subcortical structures.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  circuit; premanifest Huntington's disease; shape; subcortical structures; subregion

Mesh:

Year:  2018        PMID: 30376191      PMCID: PMC6420821          DOI: 10.1002/hbm.24456

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  80 in total

Review 1.  The reward circuit: linking primate anatomy and human imaging.

Authors:  Suzanne N Haber; Brian Knutson
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

2.  CAG repeat number governs the development rate of pathology in Huntington's disease.

Authors:  J B Penney; J P Vonsattel; M E MacDonald; J F Gusella; R H Myers
Journal:  Ann Neurol       Date:  1997-05       Impact factor: 10.422

3.  Preparing for preventive clinical trials: the Predict-HD study.

Authors:  Jane S Paulsen; Michael Hayden; Julie C Stout; Douglas R Langbehn; Elizabeth Aylward; Christopher A Ross; Mark Guttman; Martha Nance; Karl Kieburtz; David Oakes; Ira Shoulson; Elise Kayson; Shannon Johnson; Elizabeth Penziner
Journal:  Arch Neurol       Date:  2006-06

4.  Irritability in pre-clinical Huntington's disease.

Authors:  Stefan Klöppel; Cynthia M Stonnington; Predrag Petrovic; Dean Mobbs; Oliver Tüscher; David Craufurd; Sarah J Tabrizi; Richard S J Frackowiak
Journal:  Neuropsychologia       Date:  2009-10-28       Impact factor: 3.139

5.  Cognitive changes in patients with Huntington's disease (HD) and asymptomatic carriers of the HD mutation--a longitudinal follow-up study.

Authors:  Jurgen Lemiere; Marleen Decruyenaere; Gery Evers-Kiebooms; Erik Vandenbussche; Rene Dom
Journal:  J Neurol       Date:  2004-08       Impact factor: 4.849

6.  Differential loss of striatal projection systems in Huntington's disease: a quantitative immunohistochemical study.

Authors:  Y P Deng; R L Albin; J B Penney; A B Young; K D Anderson; A Reiner
Journal:  J Chem Neuroanat       Date:  2004-06       Impact factor: 3.052

7.  Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials.

Authors:  Kevin Michael Biglan; Ira Shoulson; Karl Kieburtz; David Oakes; Elise Kayson; M Aileen Shinaman; Hongwei Zhao; Megan Romer; Anne Young; Steven Hersch; Jack Penney; Karen Marder; Jane Paulsen; Kimberly Quaid; Eric Siemers; Caroline Tanner; William Mallonee; Greg Suter; Richard Dubinsky; Carolyn Gray; Martha Nance; Scott Bundlie; Dawn Radtke; Sandra Kostyk; Corrine Baic; James Caress; Francis Walker; Victoria Hunt; Christine O'Neill; Sylvain Chouinard; Stewart Factor; Timothy Greenamyre; Cathy Wood-Siverio; Jody Corey-Bloom; David Song; Guerry Peavy; Carol Moskowitz; Melissa Wesson; Ali Samii; Thomas Bird; Hillary Lipe; Karen Blindauer; Frederick Marshall; Carol Zimmerman; Jody Goldstein; Diana Rosas; Peter Novak; John Caviness; Charles Adler; Amy Duffy; Vicki Wheelock; Teresa Tempkin; David Richman; Lauren Seeberger; Roger Albin; Kelvin L Chou; Brad Racette; Joel S Perlmutter; Susan Perlman; Yvette Bordelon; Wayne Martin; Marguerite Wieler; Blair Leavitt; Lynn Raymond; Joji Decolongon; Lorne Clarke; Joseph Jankovic; Christine Hunter; Robert A Hauser; Juan Sanchez-Ramos; Sarah Furtado; Oksana Suchowersky; Mary Lou Klimek; Mark Guttman; Rustom Sethna; Andrew Feigin; Marie Cox; Barbara Shannon; Alan Percy; Leon Dure; Madaline Harrison; William Johnson; Donald Higgins; Eric Molho; Constance Nickerson; Sharon Evans; Douglas Hobson; Carlos Singer; Nestor Galvez-Jimenez; Kathleen Shannon; Cynthia Comella; Christopher Ross; Marie H Saint-Hilaire; Claudia Testa; Adam Rosenblatt; Penelope Hogarth; William Weiner; Peter Como; Rajeev Kumar; Candace Cotto; Julie Stout; Alicia Brocht; Arthur Watts; Shirley Eberly; Christine Weaver; Tatiana Foroud; James Gusella; Marcy MacDonald; Richard Myers; Stanley Fahn; Clifford Shults
Journal:  JAMA Neurol       Date:  2016-01       Impact factor: 18.302

8.  Response properties of human amygdala subregions: evidence based on functional MRI combined with probabilistic anatomical maps.

Authors:  Tonio Ball; Benjamin Rahm; Simon B Eickhoff; Andreas Schulze-Bonhage; Oliver Speck; Isabella Mutschler
Journal:  PLoS One       Date:  2007-03-21       Impact factor: 3.240

9.  Segmentation of brain magnetic resonance images based on multi-atlas likelihood fusion: testing using data with a broad range of anatomical and photometric profiles.

Authors:  Xiaoying Tang; Deana Crocetti; Kwame Kutten; Can Ceritoglu; Marilyn S Albert; Susumu Mori; Stewart H Mostofsky; Michael I Miller
Journal:  Front Neurosci       Date:  2015-03-03       Impact factor: 4.677

10.  Motor onset and diagnosis in Huntington disease using the diagnostic confidence level.

Authors:  Dawei Liu; Jeffrey D Long; Ying Zhang; Lynn A Raymond; Karen Marder; Anne Rosser; Elizabeth A McCusker; James A Mills; Jane S Paulsen
Journal:  J Neurol       Date:  2015-09-26       Impact factor: 4.849

View more
  8 in total

1.  Visualising the topography of the acoustic radiation in clinical diffusion tensor imaging scans.

Authors:  S Bryn Dhir; Kwame S Kutten; Muwei Li; Andreia V Faria; Laurent Younes; J Tilak Ratnanather
Journal:  Neuroradiology       Date:  2020-05-19       Impact factor: 2.804

2.  Vox2Surf: Implicit Surface Reconstruction from Volumetric Data.

Authors:  Yoonmi Hong; Sahar Ahmad; Ye Wu; Siyuan Liu; Pew-Thian Yap
Journal:  Med Image Comput Comput Assist Interv       Date:  2021-09-21

Review 3.  The presymptomatic phase of amyotrophic lateral sclerosis: are we merely scratching the surface?

Authors:  Rangariroyashe H Chipika; We Fong Siah; Mary Clare McKenna; Stacey Li Hi Shing; Orla Hardiman; Peter Bede
Journal:  J Neurol       Date:  2020-10-31       Impact factor: 6.682

4.  Regional subcortical shape analysis in premanifest Huntington's disease.

Authors:  Xiaoying Tang; Christopher A Ross; Hans Johnson; Jane S Paulsen; Laurent Younes; Roger L Albin; J Tilak Ratnanather; Michael I Miller
Journal:  Hum Brain Mapp       Date:  2018-10-30       Impact factor: 5.038

5.  Structural neuroimaging differentiates vulnerability from disease manifestation in colombian families with Huntington's disease.

Authors:  Maria Del C Valdés Hernández; Janna Abu-Hussain; Xinyi Qiu; Josef Priller; Mario Parra Rodríguez; Mariana Pino; Sandra Báez; Agustín Ibáñez
Journal:  Brain Behav       Date:  2019-07-05       Impact factor: 2.708

6.  The Role of Hypothalamic Pathology for Non-Motor Features of Huntington's Disease.

Authors:  Rachel Y Cheong; Sanaz Gabery; Åsa Petersén
Journal:  J Huntingtons Dis       Date:  2019

7.  Montreal Cognitive Assessment (MoCA) performance in Huntington's disease patients correlates with cortical and caudate atrophy.

Authors:  Gabriel Ramirez-Garcia; Victor Galvez; Rosalinda Diaz; Aurelio Campos-Romo; Juan Fernandez-Ruiz
Journal:  PeerJ       Date:  2022-04-04       Impact factor: 2.984

8.  Progression of basal ganglia pathology in heterozygous Q175 knock-in Huntington's disease mice.

Authors:  Yunping Deng; Hongbing Wang; Marion Joni; Radhika Sekhri; Anton Reiner
Journal:  J Comp Neurol       Date:  2020-09-20       Impact factor: 3.215

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.